AMA physicians: Pharma should be required to divulge drug prices in consumer-facing ads

The American Medical Association on June 14 will vote whether to back regulations and legislation that would force drug companies to include suggested retail prices in direct-to-consumer advertisements, reports STAT.

The resolution — proposed by six state medical societies — argues direct-to-consumer ads encourage patients to pressure their physicians into prescribing newer, more expensive medications. AMA's policymaking body — the House of Delegates — will vote on the resolution during the association's annual meeting in Chicago next week, according to STAT.

"[I]n a free enterprise system such as we have in the United States, the purchasing public should be educated," the AMA resolution reads. "[A]dvertising should be required to state the manufacturer's suggested retail price of those drugs."

In 2015, AMA unsuccessfully attempted to convince lawmakers to institute a ban on direct-to-consumer advertising for prescription drugs all together.

More articles on supply chain:

AstraZeneca divests migraine drug for $302M
Advocacy group calls for FDA action on Bayer's birth control device
Walmart pledges to slash supply chain greenhouse gas emission by 1B tons

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Content

Featured Webinars

Featured Whitepapers